Research ArticleOriginal Article
Open Access

Impact of change in the Naples prognostic score after neoadjuvant chemoradiotherapy on survival in esophageal squamous cell carcinoma patients

Haowen Zhang, Xin Xiao, Siyuan Luan, Xiaokun Li, Shangwei Sun and Yong Yuan
Saudi Medical Journal May 2024, 45 (5) 481-489; DOI: https://doi.org/10.15537/smj.2024.45.5.20230908

References

  1. 1.↵
    1. Sung H,
    2. Ferlay J,
    3. Siegel RL,
    4. Laversanne M,
    5. Soerjomataram I,
    6. Jemal A. et al.
    Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209–249.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Obermannová R,
    2. Alsina M,
    3. Cervantes A,
    4. Leong T,
    5. Lordick F,
    6. Nilsson M. et al.
    Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022; 33: 992–1004.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bolger JC,
    2. Donohoe CL,
    3. Lowery M,
    4. Reynolds JV.
    Advances in the curative management of oesophageal cancer. Brit J Cancer 2022; 126: 706–717.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Adiamah A,
    2. Skořepa P,
    3. Weimann A,
    4. Lobo DN.
    The impact of preoperative immune modulating nutrition on outcomes in patients undergoing surgery for gastrointestinal cancer. Ann Surg 2019; 270: 247–256.
    OpenUrlPubMed
  5. 5.↵
    1. Bossi P,
    2. Delrio P,
    3. Mascheroni A,
    4. Zanetti M.
    The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients 2021; 13: 1980.
    OpenUrlCrossRef
  6. 6.↵
    1. Okadome K,
    2. Baba Y,
    3. Yagi T,
    4. Kiyozumi Y,
    5. Ishimoto T,
    6. Iwatsuki M. et al.
    Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg 2020; 271: 693–700.
    OpenUrlCrossRefPubMed
  7. 7.
    1. Feng J,
    2. Wang L,
    3. Yang X,
    4. Chen Q,
    5. Cheng X.
    The usefulness of pretreatment controlling nutritional status score for predicting recurrence in patients with esophageal squamous cell carcinoma undergoing neoadjuvant immunochemotherapy: A real-world study. Front Immunol 2022; 13: 1015365.
    OpenUrl
  8. 8.↵
    1. McSorley ST,
    2. Lau HYN,
    3. McIntosh D,
    4. Forshaw MJ,
    5. McMillan DC,
    6. Crumley AB.
    Staging the tumor and staging the host: pretreatment combined neutrophil lymphocyte ratio and modified glasgow prognostic score is associated with overall survival in patients with esophagogastric cancers undergoing treatment with curative intent. Ann Surg Oncol 2021; 28: 722–731.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Galizia G,
    2. Lieto E,
    3. Auricchio A,
    4. Cardella F,
    5. Mabilia A,
    6. Podzemny V. et al.
    Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum 2017; 60: 1273–1284.
    OpenUrlCrossRef
  10. 10.↵
    1. Kano K,
    2. Yamada T,
    3. Yamamoto K,
    4. Komori K,
    5. Watanabe H,
    6. Takahashi K. et al.
    The impact of pretherapeutic naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol 2021; 28: 4530–4539.
    OpenUrlCrossRef
  11. 11.↵
    1. Yoon HG,
    2. Oh D,
    3. Ahn YC,
    4. Noh JM,
    5. Pyo H,
    6. Cho WK. et al.
    Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers 2020; 12: 925.
    OpenUrl
  12. 12.↵
    1. Choi H,
    2. Noh H,
    3. Cho I,
    4. Lim S,
    5. Han A.
    Changes in neutrophil to lymphocyte ratio (NLR) during neoadjuvant treatment correlated with patients’ survival. Breast Cancer-Tokyo 2020; 27: 871–879.
    OpenUrl
  13. 13.↵
    1. Yu H,
    2. Kortylewski M,
    3. Pardoll D.
    Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7: 41–51.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Coussens LM,
    2. Werb Z.
    Inflammation and cancer. Nature 2002; 420: 860–867.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. di Pietro M,
    2. Canto MI,
    3. Fitzgerald RC.
    Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology 2018; 154: 421–36.
    OpenUrl
  16. 16.↵
    1. Wang P,
    2. Chen X,
    3. Liu Q,
    4. Xu L,
    5. Zhang R,
    6. Liu X. et al.
    Application of four nutritional risk indexes in perioperative management for esophageal cancer patients. J Cancer Res Clin 2021; 147: 3099–111.
    OpenUrl
  17. 17.↵
    1. Jiang Y,
    2. Xu D,
    3. Song H,
    4. Qiu B,
    5. Tian D,
    6. Li Z. et al.
    Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis. Bmj Open 2021; 11: e48324.
    OpenUrl
  18. 18.↵
    1. Chen Y,
    2. Guan Z,
    3. Shen G.
    Naples prognostic score: a novel predictor of survival in patients with HER2-positive breast cancer. Future Oncol 2022; 18: 2655–65.
    OpenUrlCrossRef
  19. 19.↵
    1. Xiong J,
    2. Hu H,
    3. Kang W,
    4. Liu H,
    5. Ma F,
    6. Ma S. et al.
    Prognostic impact of preoperative naples prognostic score in gastric cancer patients undergoing surgery. Front Surg 2021; 8: 617744.
    OpenUrl
  20. 20.↵
    1. Xuan J,
    2. Peng J,
    3. Wang S,
    4. Cai Y.
    Prognostic significance of Naples prognostic score in non-small-cell lung cancer patients with brain metastases. Future Oncol 2022; 18: 1545–1555.
    OpenUrl
  21. 21.↵
    1. de Mattos ÂZ,
    2. Simonetto DA,
    3. Terra C,
    4. Farias AQ,
    5. Bittencourt PL,
    6. Pase THS. et al.
    Albumin administration in patients with cirrhosis: Current role and novel perspectives. World J Gastroentero 2022; 28: 4773–4786.
    OpenUrl
  22. 22.↵
    1. Kritchevsky SB,
    2. Kritchevsky D.
    Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 1992; 12: 391–416.
    OpenUrlPubMedWeb of Science
  23. 23.↵
    1. Li K,
    2. Xia X,
    3. Su M,
    4. Zhang H,
    5. Chen W,
    6. Zou C.
    Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. Bmc Cancer 2019; 19.
  24. 24.↵
    1. Chen Y,
    2. Guan Z,
    3. Shen G.
    Naples prognostic score: a novel predictor of survival in patients with HER2-positive breast cancer. Future Oncol 2022; 18: 2655–2665.
    OpenUrlCrossRef
  25. 25.↵
    1. Nakagawa N,
    2. Yamada S,
    3. Sonohara F,
    4. Takami H,
    5. Hayashi M,
    6. Kanda M. et al.
    Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer. Ann Surg Oncol 2020; 27: 887–95.
    OpenUrlCrossRef
  26. 26.↵
    1. Schuchert MJ,
    2. Abbas G,
    3. Nason KS,
    4. Pennathur A,
    5. Awais O,
    6. Santana M. et al.
    Impact of anastomotic leak on outcomes after transhiatal esophagectomy. Surgery 2010; 148: 831–840.
    OpenUrlPubMed
  27. 27.↵
    1. Takahashi K,
    2. Nishikawa K,
    3. Tanishima Y,
    4. Ishikawa Y,
    5. Kobayashi T,
    6. Masuda T. et al.
    Risk stratification of anastomotic stricture using early postoperative endoscopic and computed tomography findings in patients undergoing esophagectomy with cervical esophagogastric anastomosis for esophageal cancer. Dis Esophagus 2022; 35: doac004.a
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords